<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">Childhood cancer</z:e> survivors were at risk of development of second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study is to evaluate the incidence, risk factors and outcome of second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> in <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancer</z:e> survivors in a tertiary paediatric <z:hpo ids='HP_0002664'>oncology</z:hpo> centre in Hong Kong, China </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We performed a retrospective review of patients with <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancer</z:e> treated in Children's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Centre in Prince of Wales Hospital, Hong Kong, China between May 1984 and June 2009 </plain></SENT>
<SENT sid="3" pm="."><plain>Case records of patients who developed second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> were reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Totally 1374 new cases aged less than 21-year old were treated in our centre in this 25-year study period </plain></SENT>
<SENT sid="5" pm="."><plain>Twelve cases developed second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> with 10-year and 20-year cumulative incidence of 1.3% (95% confidence interval 0.3% - 2.3%) and 2.9% (95% confidence interval 1.1% - 4.7%) respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Another 4 cases were referred to us from other centres for the management of second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In this cohort of 16 children with second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, the most frequent second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> were <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (n = 6) and central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (n = 4) </plain></SENT>
<SENT sid="8" pm="."><plain>Median interval between diagnosis of primary and second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> was 7.4 years (range 2.1 - 13.3 years) </plain></SENT>
<SENT sid="9" pm="."><plain>Eight patients developed second <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> within the previous irradiated field </plain></SENT>
<SENT sid="10" pm="."><plain>Radiotherapy significantly increased the risk of development of second <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> in patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (P = 0.027) </plain></SENT>
<SENT sid="11" pm="."><plain>Seven out of 16 patients who developed second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> had a family history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> among the first or second-degree relatives </plain></SENT>
<SENT sid="12" pm="."><plain>Nine patients died of progression of second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, mainly resulted from second central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Cumulative incidence of <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second cancer</z:e> in our centre was comparable to western countries </plain></SENT>
<SENT sid="14" pm="."><plain>Radiotherapy was associated with second <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumour</z:e> among patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain>Patients who developed second <z:mp ids='MP_0009277'>brain tumor</z:mp> and <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> had a poor outcome </plain></SENT>
</text></document>